# G5-RNA-Seq

## Supplementary Resource to:

Karn T et al. Predictive value of molecular hypoxia signature for bevacizumab response in neoadjuvant GeparQuinto breast cancer trial.

*Pubmed:*

[https://www.ncbi.nlm.nih.gov/pubmed/?term=](https://www.ncbi.nlm.nih.gov/pubmed/?term=)

************************************************************

## This resource contains the following data files and scripts used in the analyses described in the Methods of the paper:


* 
